Leptomeningeal Disease clinical trials

Explore recruiting leptomeningeal disease clinical trials.

Recruiting leptomeningeal disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Leptomeningeal Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Intrathecal application of PD-1 antibody in metastatic solid tumors with leptomeningeal disease

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase II Study of Trastuzumab-Deruxtecan (T-DXd; DS-8201a) in HER2-Low Breast Cancer Patients Presenting with Newly Diagnosed or Progressing Brain Metastases. (The TUXEDO-4 Study)

Austria, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A MULTICENTER, SINGLE-ARM, THREE COHORT, PHASE II TRIAL OF PATRITUMAB DERUXTECAN (HER3-DXD) IN PATIENTS WITH ACTIVE BRAIN METASTASES FROM HER3-EXPRESSING ADVANCED BREAST CANCER AND NON–SMALL CELL LUNG CANCER, AND IN PATIENTS WITH LEPTOMENINGEAL CARCINOMATOSIS FROM HER3-EXPRESSING ADVANCED SOLID TUMORS (The TUXEDO-3 Study)

Austria, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Leptomeningeal Disease trials by city

Leptomeningeal Disease in Toronto Leptomeningeal Disease in Vancouver Leptomeningeal Disease in Montreal Leptomeningeal Disease in Calgary Leptomeningeal Disease in Edmonton Leptomeningeal Disease in Ottawa Leptomeningeal Disease in Winnipeg Leptomeningeal Disease in Quebec City Leptomeningeal Disease in Hamilton Leptomeningeal Disease in Kitchener Leptomeningeal Disease in London Leptomeningeal Disease in Halifax Leptomeningeal Disease in New York Leptomeningeal Disease in Los Angeles Leptomeningeal Disease in Chicago Leptomeningeal Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease